Accueil > Actualité
Actualite financiere : Actualite bourse

Almirall: FDA accepts expanded indication for acne drug

(CercleFinance.com) - US health regulators have accepted approval to Almirall's Aczone acne drug to include patients aged 9-11, the Spanish drugmaker said on Wednesday.


Aczone 7.5% gel is a prescription medicine used on the skin to treat inflammatory and non-inflammatory acne, previously approved in February 2016 for patients of 12 years and older.

While acne may be commonly thought of as an issue for teenagers, it also exists for children under the age of 12.

Copyright (c) 2019 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.